Abbott Laboratories (ABT)
Financial leverage ratio
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 84,181,000 | 83,999,000 | 81,448,000 | 81,414,000 | 74,356,000 | 73,017,000 | 72,467,000 | 73,214,000 | 72,090,000 | 73,354,000 | 73,794,000 | 74,438,000 | 72,801,000 | 74,202,000 | 74,007,000 | 75,196,000 | 73,795,000 | 73,269,000 | 72,785,000 | 72,548,000 |
| Total stockholders’ equity | US$ in thousands | 50,954,000 | 50,565,000 | 48,811,000 | 47,664,000 | 39,796,000 | 39,318,000 | 38,810,000 | 38,603,000 | 37,481,000 | 37,174,000 | 74,219,000 | 36,686,000 | 35,675,000 | 36,490,000 | 35,399,000 | 35,802,000 | 34,422,000 | 33,800,000 | 33,562,000 | 32,784,000 |
| Financial leverage ratio | 1.65 | 1.66 | 1.67 | 1.71 | 1.87 | 1.86 | 1.87 | 1.90 | 1.92 | 1.97 | 0.99 | 2.03 | 2.04 | 2.03 | 2.09 | 2.10 | 2.14 | 2.17 | 2.17 | 2.21 |
September 30, 2025 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $84,181,000K ÷ $50,954,000K
= 1.65